Skip to content
healthcare.dev

Insulin Aspart Protamine and Insulin Aspart Mix 70/30

NDC 73070-200, insulin aspart, injection, suspension, from Novo Nordisk Pharma, Inc..

Product NDC
73070-200
Status
Listed
Labeler
Novo Nordisk Pharma, Inc.
Dosage form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA021172
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73070-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN ASPART100 [iU]/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
73070-200-11730700200111 VIAL, GLASS in 1 CARTON (73070-200-11) / 10 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fc94baa4-3606-48bc-a781-9617ab6960ef
  • NADAC price for package 73070020011

    GET /v1/drugs/nadac/73070020011

Use it

Look up 73070-200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73070-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73070-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.